These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24481065)

  • 1. Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.
    Sesen J; Cammas A; Scotland SJ; Elefterion B; Lemarié A; Millevoi S; Mathew LK; Seva C; Toulas C; Moyal EC; Skuli N
    Int J Mol Sci; 2014 Jan; 15(2):2172-90. PubMed ID: 24481065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased eIF3e/Int6 expression causes epithelial-to-mesenchymal transition in breast epithelial cells.
    Gillis LD; Lewis SM
    Oncogene; 2013 Aug; 32(31):3598-605. PubMed ID: 22907435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bad, the Good and eIF3e/INT6.
    Sesen J; Casaos J; Scotland SJ; Seva C; Eisinger-Mathason TS; Skuli N
    Front Biosci (Landmark Ed); 2017 Jan; 22(1):1-20. PubMed ID: 27814599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression.
    Chen L; Endler A; Uchida K; Horiguchi S; Morizane Y; Iijima O; Toi M; Shibasaki F
    Circulation; 2010 Aug; 122(9):910-9. PubMed ID: 20713899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Int6 silencing causes induction of angiogenic factors in neuronal cells via accumulation of hypoxia-inducible factor 2α and decreases brain damage in rats.
    Miyashita R; Chen L; Oshiro H; Uchino H; Shibasaki F
    Neurosci Lett; 2012 Oct; 528(1):83-8. PubMed ID: 22960363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle-related variation in subcellular localization of eIF3e/INT6 in human fibroblasts.
    Watkins SJ; Norbury CJ
    Cell Prolif; 2004 Apr; 37(2):149-60. PubMed ID: 15030549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.
    Suo J; Snider SJ; Mills GB; Creighton CJ; Chen AC; Schiff R; Lloyd RE; Chang EC
    Oncogene; 2011 Feb; 30(6):724-36. PubMed ID: 20890303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INT6/eIF3e represses E-cadherin expression through HIF2α in lung carcinoma A549 cells.
    Gotoh-Saito S; Sadato D; Shibasaki F
    Genes Cells; 2022 Dec; 27(12):689-705. PubMed ID: 36116043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation.
    Chen L; Uchida K; Endler A; Shibasaki F
    J Biol Chem; 2007 Apr; 282(17):12707-16. PubMed ID: 17324924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Int6/eIF3e silenced HIF2α stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling.
    Endler A; Chen L; Li Q; Uchida K; Hashimoto T; Lu L; Xu GT; Shibasaki F
    Cytokine; 2013 Apr; 62(1):115-22. PubMed ID: 23478175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation.
    Sadato D; Ono T; Gotoh-Saito S; Kajiwara N; Nomura N; Ukaji M; Yang L; Sakimura K; Tajima Y; Oboki K; Shibasaki F
    FEBS Open Bio; 2018 Aug; 8(8):1188-1201. PubMed ID: 30087825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of eIF3e promotes blood perfusion recovery after limb ischemia through stabilization of hypoxia-inducible factor 2α activity.
    Hashimoto T; Chen L; Kimura H; Endler A; Koyama H; Miyata T; Shibasaki F; Watanabe T
    J Vasc Surg; 2016 Jul; 64(1):219-226.e3. PubMed ID: 25758454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor as an angiogenic master switch.
    Hashimoto T; Shibasaki F
    Front Pediatr; 2015; 3():33. PubMed ID: 25964891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human INT6/eIF3e is required for nonsense-mediated mRNA decay.
    Morris C; Wittmann J; Jäck HM; Jalinot P
    EMBO Rep; 2007 Jun; 8(6):596-602. PubMed ID: 17468741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells.
    Morris C; Tomimatsu N; Richard DJ; Cluet D; Burma S; Khanna KK; Jalinot P
    Cancer Res; 2012 Apr; 72(8):2006-16. PubMed ID: 22508697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo.
    Fiorenzo P; Mongiardi MP; Dimitri D; Cozzolino M; Ferri A; Montano N; Trevisi G; Maira G; Battistini L; Falchetti ML; Levi A; Pallini R
    Int J Oncol; 2010 Apr; 36(4):785-91. PubMed ID: 20198320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of truncated eukaryotic initiation factor 3e (eIF3e) resulting from integration of mouse mammary tumor virus (MMTV) causes a shift from cap-dependent to cap-independent translation.
    Chiluiza D; Bargo S; Callahan R; Rhoads RE
    J Biol Chem; 2011 Sep; 286(36):31288-96. PubMed ID: 21737453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oncogenic role of eIF3e/INT6 in human breast cancer.
    Grzmil M; Rzymski T; Milani M; Harris AL; Capper RG; Saunders NJ; Salhan A; Ragoussis J; Norbury CJ
    Oncogene; 2010 Jul; 29(28):4080-9. PubMed ID: 20453879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
    Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
    FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.